In recent discussions about drug policy reform, the spotlight has increasingly focused on how European Union (EU) Member States navigate their international and EU obligations while reevaluating their stance on cannabis.
This complex legal landscape offers both challenges and opportunities for reform. Benjamin-Alexandre Jeanroy, CEO of Augur Associates, and Kenzi Riboulet-Zemouli, independent researcher, explain what you need to know.
Read more on Krautinvest
Support the work by Kenzi and his team next week at the UN CND session in Vienna. Their dedication and involvement are crucial for the worldwide cannabis and hemp legal markets.